Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: IMO, we are in a crisis. In 6 months we could be begging for a Swartz loan.

You miss my point. We aren't experiencing $4M/qtr in operating expenses. You are counting the PDS expense twice, IMO. Unless you can show me how the PDS contribution is not considered an operating expense of PTSC.

And the rest of my message?

SGE

Share
New Message
Please login to post a reply